|
WO2019213214A1
|
|
Compounds for treating chronic pain
|
|
WO2016123107A1
|
|
Nanoparticle polymer grafted dispersants and unimolecular micelles and methods of use
|
|
WO2015157312A1
|
|
Systems, devices, and methods for automated endotracheal suctioning
|
|
US2015037371A1
|
|
Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens
|
|
WO2014172577A1
|
|
Adaptable viewing port for endotracheal tube
|
|
WO2014172452A1
|
|
Cancer detection using urinary reporter exression-targeted gene delivery
|
|
WO2014137496A1
|
|
Mu opioid receptor agonist analogs of the endomorphins
|
|
CA2883474A1
|
|
Drug delivery devices and methods of making and using same
|
|
US2014243256A1
|
|
Arenavirus inhibiting peptides and uses therefor
|
|
US2014271580A1
|
|
Immunoprotective primary mesenchymal stem cells and methods
|
|
US2013178427A1
|
|
Mu opioid receptor agonist analogs of the endomorphins
|
|
WO2013123517A1
|
|
Hollow nanoparticles with hybrid double layers
|
|
WO2013074966A1
|
|
Use of pituitary adenylate cyclase activating polypeptide (pacap) and pacap analogs for treating contrast -indused nephropathy
|
|
EP2776831A1
|
|
Paper based diagnostic test
|
|
CN103608449A
|
|
Underground reactor system
|
|
WO2012139068A2
|
|
Co-administration of arsenic compounds and anti-herpes virus anti-virals
|
|
WO2012138911A2
|
|
Conjugates of anti-hiv drugs and somatostatin analogs
|
|
CA2830073A1
|
|
Multi-component detachable jaw tools and methods of using and making same
|
|
CN103547906A
|
|
A device and method for monitoring the presence, onset and evolution of particulates in chemically or physically reacting systems
|
|
WO2012051210A2
|
|
Mesenchymal stem cells and related therapies
|
